← 返回

小分子也能成大事:靶向 PTPN2/PTPN1 的小分子抑制剂用于肿瘤免疫治疗

英文原题:Little ones can do big things: Small molecule inhibitors target PTPN2/PTPN1 for tumor immunotherapy.

查看英文原题

Little ones can do big things: Small molecule inhibitors target PTPN2/PTPN1 for tumor immunotherapy.

PubMed 2024/05/29(内容时间) MedComm (2020) Q1 · IF 14.1(JCR 2025)

分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。

中文摘要

AC484是基于PTPN2蛋白结构设计化合物而开发的。AC484通过多种机制增强抗肿瘤免疫:增加肿瘤对IFN-γ的敏感性、改善T细胞功能、刺激肿瘤微环境炎症、扩大TCR多样性以及防止T细胞耗竭。有趣的是,AC484的疗效也由CD8+和NK细胞介导。

展开英文摘要原文

AC484 was developed by designing compounds based on the PTPN2 protein structure. AC484 enhances antitumor immunity through multiple mechanisms: increasing tumor sensitivity to IFN-γ, improving T-cell functions, stimulating tumor microenvironment inflammation, expanding TCR diversity, and preventing T-cell exhaustion. Interestingly, the efficacy of AC484 was also mediated by CD8+ and NK cells.

论文信息

作者
Wang J、Qin S、Zhang A
单位
Department of Rehabilitation Medicine Shanghai Fourth People's Hospital, School of Medicine, Tongji University Shanghai China.China
期刊
MedComm2024 Jun
原文标识
PubMed 38817652 · DOI 10.1002/mco2.567